Cardiology
From the Journals
Obesity-related cardiovascular disease deaths surging
“There is need for dedicated health strategies aimed at individual communities to better understand and tackle the social determinants of obesity...
Commentary
The most important study from ESC: FRAIL-AF
This is the kind of science that medicine should celebrate. There were no soft endpoints, financial conflicts, or spin.
Conference Coverage
Dietary nitrates reduce contrast-induced nephropathy in ACS
“Currently, aside from intravenous hydration, there is no proven treatment that reduces contrast-induced nephropathy. We feel that dietary...
Conference Coverage
Screening finds high rates of CVD in diabetes, COPD patients
The study tested a “very simple” symptom questionnaire as the initial screening phase, yet resulted in a CVD diagnostic rate that was two- to...
Conference Coverage
More weight loss linked with more benefit in STEP-HFpEF
“The outcomes we’ve already seen in STEP-HFpEF were largely symptomatic, which are extraordinarily important, but there may be a completely...
Conference Coverage
Anticoagulation no benefit in presumed AFib detected by cardiac devices
“Based on the result of this trial, these occasional atrial high-rate episodes do not appear to be associated with stroke. It appears quite benign...
Conference Coverage
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
Another major change in the new ESC guideline revision is introduction of a CVD risk calculator intended to estimate the risk among people with...
Conference Coverage
Wegovy scores HFpEF benefits in people with obesity
The results “indicate that treatment with semaglutide is a valuable therapeutic approach in the management of patients with HFpEF and obesity.”
From the Journals
Dementia diagnosis a good time to reduce polypharmacy
Time of diagnosis can be a potential inflexion point for deprescribing long-term medications with safety risks, limited benefit, or possible...
From the Journals
Simple blood test may predict heart and kidney risk in T2D
“Three out of the four biomarkers are already clinically and commercially available,” while the fourth, for insulin-like growth factor binding...
Latest News
Low-dose oral minoxidil for female pattern hair loss: Benefits, impact on BP, heart rate evaluated
“It was surprising how little ambulatory blood pressure and heart rate changed after an average of 6 months of treatment,” one of the authors said...